The BioCanRx network is changing the face of cancer treatment
BioCanRx’s vision is to cure patients and enhance the quality of life of those living with cancer. We will do this by supporting world-class research in the area of immune oncology, and by accelerating to the clinic the most promising cancer immunotherapies designed to save lives and enable a better quality of life. Through an innovative, collaborative funding process BioCanRx is becoming a world-leader in the translation, manufacture and adoption of leading edge cancer immunotherapy treatments for the benefit of cancer patients.
Making an obvious target attainable
In pancreatic cancer, the gene where hotspot mutations occur is known as KRAS. It has been recognized for at least 30 years, making it “so frustrating” that this knowledge has not translated to any clinical improvements.
Learn more →
Summit4CI 2021 Keynote Announced
BioCanRx is pleased to announce Dr. Carl H. June as our distinguished keynote speaker for the 2021 Summit for Cancer Immunotherapy taking place November 20-22, 2021.
Learn more →
Where Are They Now: Nicole Forbes
We are pleased to introduce Nicole Forbes, who worked in the lab of Dr. Jean-Simon Diallo in Ottawa, Ontario. She now works at the Public Health Agency of Canada (PHAC).
Learn more →
Join the BioCanRx Network at the 5th annual Summit for Cancer Immunotherapy (Summit4CI) in Montréal!
November 20-22, 2021
Fairmont The Queen Elizabeth Hotel
